Cerevel Therapeutics investor relations material

Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of various therapies for neuroscience diseases. Cerevel Therapeutics Holdings, Inc. operates as a clinical-stage biopharmaceutical company. The company focuses on developing therapies for neurology diseases, such as Alzheimer and Parkinson's disease. It develops therapeutics in the areas of intracerebral drug delivery system, biomarkers and imaging tools, anti-inflammatory therapeutics, anti-amyloid antibodies, central nervous toxicity and other drug candidates. The company was formerly known as Cerevel Therapeutics PLC.